EMEA-000380-PIP01-08-M04

Key facts

Invented name
Cosentyx
Active substance
Secukinumab
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0352/2017
PIP number
EMEA-000380-PIP01-08-M04
Pharmaceutical form(s)
  • Powder for solution for injection
  • Solution for injection
Condition(s) / indication(s)
Treatment of psoriasis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Novartis Europharm Ltd
Tel. +41 613249752
E-mail: paediatric.enquiries@novartis.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating